Neurology
RSSArticles
-
Clinical Briefs
In this section: treating COPD with statins, tackling hearing loss with greater urgency, and educating patients about malignant melanomas. -
Insulin Lispro Injection (Admelog)
Admelog is indicated to improve glycemic control in adults and pediatric patients ≥ 3 years of age with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.
-
Clostridium difficile Recurrence by Orally Administered Fecal Microbiota Transplantation
Fecal microbiota transplantation orally administered in capsules was non-inferior to administration by colonoscopy.
-
Blockade of CGRP for Migraine Prevention: Promising, but Not a Cure
Blockade of calcitonin gene-related peptide in patients with chronic or episodic migraine results in the prevention of about two headache days a month compared to placebo.
-
Obesity Is a Hormonal Illness
Once obese, a patient’s metabolism adapts with insulin resistance to maintain body fat. High insulin levels promote fat storage and block fat burning.
-
NOTICE: February 2018 was the final issue of this publication.
Contact customer service at 800-688-2421 or email [email protected] to transfer your subscription to another publication.
-
Serum Tau as a Reliable Biomarker of Outcome After Cardiac Arrest
Currently, there are no reliable and readily available biomarkers to assist in determining prognosis for neurological recovery after cardiac arrest, but serum tau measurements hold promise for the future.
-
Pain in Anti-MAG Neuropathy
Most patients with anti-MAG neuropathy complain of painful paresthesias or dysesthesias, but unlike diabetic neuropathy, these symptoms are not severe and do not affect quality of life as much as motor weakness.
-
Myasthenia Gravis, MuSK, and Pregnancy
Myasthenia gravis increases both maternal and fetal complications and mortality during pregnancy, but the MuSK-antibody variant appears less morbid, based on this small retrospective series of 17 patients.
-
Functional Imaging Studies in Parkinson’s Disease
A meta-analysis of 142 studies demonstrated that functional imaging studies in Parkinson’s disease using tracers for aromatic acid decarboxylase showed smaller defects compared to those using tracers targeting dopamine transport and VMAT2. Symptom severity correlated linearly with dopamine neuron loss as determined by these imaging studies.